← Evidence map

ArticleThe lancet. Diabetes & endocrinology2024

Sodium-glucose co-transporter type-2 inhibitors for hospitalised patients with COVID-19: safe but not protective.

André J ScheenPubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 39250920